CONMED CORPORATION Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax
CONMED CORPORATION (CNMD) had Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax of $18.86 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan
us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax · last filed 2026-02-17
- 2025-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $18.86M.
- 2024-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $22.28M.
- 2023-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $24.77M.
- 2022-12-31: Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax $31.35M.
| Period end | Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax | Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax as first filed |
|---|---|---|
| 2025-12-31 | $18.86M 10-K · filed 2026-02-17 | |
| 2024-12-31 | $22.28M 10-K · filed 2026-02-17 | |
| 2023-12-31 | $24.77M 10-K · filed 2025-02-18 | |
| 2022-12-31 | $31.35M 10-K · filed 2024-02-28 | |
| 2021-12-31 | $39.12M 10-K · filed 2023-02-21 | |
| 2020-12-31 | $48.28M 10-K · filed 2022-02-22 | |
| 2019-12-31 | $41.79M 10-K · filed 2021-02-22 | |
| 2018-12-31 | $41.82M 10-K · filed 2020-02-24 | |
| 2017-12-31 | $40.94M 10-K · filed 2019-02-25 | |
| 2016-12-31 | $41.96M 10-K · filed 2018-02-26 | |
| 2015-12-31 | $41.20M 10-K · filed 2017-02-27 | |
| 2014-12-31 | $48.78M 10-K · filed 2016-02-23 | |
| 2013-12-31 | $30.00M 10-K · filed 2015-02-23 | |
| 2012-12-31 | $48.18M 10-K · filed 2014-02-24 | |
| 2011-12-31 | $49.56M 10-K · filed 2013-02-25 | $29.31M 10-K · filed 2012-02-28 |
| 2010-12-31 | $49.56M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |